Clinical Trials Browser

Biliary Tract Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Renal Cell

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular, Liver Neoplasms

Colorectal Neoplasms

Carcinoma, Ovarian Neoplasms

Colorectal Cancer Metastatic

Colorectal Cancer Metastatic

Neuroma, Acoustic, Neurofibromatosis 2

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Carcinoma, Non-Small-Cell Lung

Elderly Metastatic Colorectal Cancer Patients

Colorectal Neoplasms

Colorectal Neoplasms

Kidney Neoplasms, Lung Neoplasms, Melanoma

Brain Neoplasms, Glioblastoma

Colorectal Neoplasms

Lung Neoplasms, Surgical Wound Infection, Colorectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Breast Cancer Organoids

Colorectal Cancer Metastatic

Ovarian Neoplasms

Colorectal Neoplasms

Breast Neoplasms

Colorectal Neoplasms

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Colorectal Neoplasms

Breast Neoplasms, Hypertension

Colorectal Neoplasms

Colorectal Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Anus Neoplasms, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Clinical Trials

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC

International Multicentric Study ARON-1

HCC

Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis

CCGLC-001

Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer

OVNI-B

A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer

Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

HCC

Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer

COBRA

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC

Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer

Microbiome Immunotherapy Toxicity and Response Evaluation

Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI

a Prospective Registration Study for Patients With Advanced Refractory Solid Tumors

Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical Study

The Effects of Preoperative Bevacizumab on Perioperative Complications

BELLA

ROBOT

Breast Cancer Treatment Based on Organ-like Culture

AVOCETTE

REBECA

CIRCUS

Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer

COBEQOL

ENCOURAGE

BevaRet

An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer

Hypertension in Breast Cancer Patients Receiving Bevacizumab

Safety Study of Bevacizumab Plus Chemotherapy To Treat Metastatic Colorectal Cancer

Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patients

VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer

Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project

A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer

First-line FOLFOXIRI Plus Bevacizumab in BRAF Mutant Metastatic Colorectal Cancer